AI patient management company Current Health disclosed on Tuesday the completion of USD11.5m under its Series A funding round led by MMC Ventures.
Legal & General, the FTSE 100 life insurer, is Current Health's first corporate investor and the largest investor in the round. Additionally, Par Equity and Scottish Investment Bank, the investment arm of Scottish Enterprise, participated in this round.
The capital will be used by Current Health to scale its patient management platform, with the goal of preventing illness for one million patients around the world by 2021. It uses wearable and wireless vital signs monitoring, clinical indicators from an ecosystem of more than 50 integrations and symptoms collected via its patient engagement tools, to continuously track patient health trends.
Under the next stage of its growth, the company will open a US headquarters in New York City as well as appointed Richard Lennox as its new COO and Sean Ginney as VP of Sales.
Nuevocor names new chief medical officer
ELIAS Animal Health names new chief revenue officer
enGene Holdings names new senior vice president, Urologic Oncology and Clinical Development
HealthTrackRx names new chief medical officer
PureTech announces launch of Seaport Therapeutics with USD100m Series A financing
REVIAN names new vice president of Healthcare Sales
Orsini Specialty Pharmacy names new CFO and EVP of Trade Relations and Account Management
Ligand Pharmaceuticals launches Pelthos Therapeutics to drive ZELSUVMI commercialisation
Soligenix announces agreement on design for second Phase 3 trial for HyBryte with EMA
Ratio Therapeutics names new chief business officer and director
Trevi Therapeutics names new vice president of Clinical Development
NeoImmuneTech names new president and chief executive officer